Latest news
Should Gilead’s Swing to a Full‑Year Loss Outlook Require Action From Gilead Sciences (GILD) Investors? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:25:24 GMTGILD Q2 Earnings Call Raises Outlook on HIV and PrEP Strength - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 14:00:00 GMTCzech National Bank Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeatMarketBeat · Fri, 07 Aug 2026 11:49:10 GMTPensionDanmark Pensionsforsikringsaktieselskab Purchases 25,515 Shares of Gilead Sciences, Inc. $GILD - MarketBeatMarketBeat · Fri, 07 Aug 2026 10:33:12 GMTNewEdge Advisors LLC Buys 231,715 Shares of Gilead Sciences, Inc. $GILD - MarketBeatMarketBeat · Fri, 07 Aug 2026 09:20:52 GMTGilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:32:35 GMTGILD SWOT Analysis: Significant Losses Highlighted in 10-Q Filin - GuruFocusGuruFocus · Fri, 07 Aug 2026 06:22:30 GMTGilead Sciences (NASDAQ: GILD) sets up automatic shelf for wide range of securities - Stock TitanStock Titan · Thu, 06 Aug 2026 21:04:35 GMT